Involvement of LPA1 receptor signaling in cerebral ischemia-induced neuropathic pain

Neuroscience

Volumn 235, Issue , 2013, Pages 10-15

  Halder, S K ^a   Yano, R ^a   Chun, J ^b   Ueda, H ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

A fibers; Cerebral ischemia; LPA1 receptor; Neuropathic pain

Indexed keywords

LYSOPHOSPHATIDIC ACID 1 RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR; UNCLASSIFIED DRUG;

AFFERENT NERVE GROUP 1; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA NERVE FIBER; BRAIN ISCHEMIA; DELTA NERVE FIBER; DISEASE DURATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE FIBER C; NEUROPATHIC PAIN; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CEREBRAL ARTERY DISEASE; CHRONIC PAIN; ELECTROSTIMULATION; GENETICS; HEMISPHERIC DOMINANCE; IMMUNOHISTOCHEMISTRY; MOUSE MUTANT; NERVE FIBER; NEURALGIA; PAIN ASSESSMENT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN ISCHEMIA; CHRONIC PAIN; ELECTRIC STIMULATION; FUNCTIONAL LATERALITY; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE FIBERS; NEURALGIA; PAIN MEASUREMENT; RECEPTORS, LYSOPHOSPHATIDIC ACID; SIGNAL TRANSDUCTION;

EID: 84873720189     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.01.005     Document Type: Article

References (46)

1. Boivie J., Leijon G., Johansson I. Central post-stroke pain - a study of the mechanisms through analyses of the sensory abnormalities. Pain 1989, 37:173-185.
2. Bowsher D. The management of central post-stroke pain. Postgrad Med J 1995, 71:598-604.
3. Bowsher D. Central pain: clinical and physiological characteristics. J Neurol Neurosurg Psychiatry 1996, 61:62-69.
4. Bowsher D. Stroke and central poststroke pain in an elderly population. J Pain 2001, 2:258-261.
5. Bowsher D. Allodynia in relation to lesion site in central post-stroke pain. J Pain 2005, 6:736-740.
6. Brigo F., Rossini F., Stefani A., Tocco P., Fiaschi A., Salviati A. Atypical presentation of thalamic post-stroke pain. Neurol Sci 2012, 10.1007/s10072-012-1162-2.
7. Feigin V.L. Stroke epidemiology in the developing world. Lancet 2005, 365:2160-2161.
8. Halder S.K., Matsunaga H., Ueda H. Neuron-specific non-classical release of prothymosin alpha: a novel neuroprotective damage-associated molecular patterns. J Neurochem 2012, 123:262-275.
9. Hansson P. Post-stroke pain case study: clinical characteristics, therapeutic options and long-term follow-up. Eur J Neurol 2004, 11:22-30.
10. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988, 32:77-88.
11. Harukuni I., Bhardwaj A. Mechanisms of brain injury after global cerebral ischemia. Neurol Clin 2006, 24:1-21.
12. Henry J.L., Lalloo C., Yashpal K. Central poststroke pain: an abstruse outcome. Pain Res Manag 2008, 13:41-49.
13. Inoue M., Rashid M.H., Fujita R., Contos J.J., Chun J., Ueda H. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med 2004, 10:712-718.
14. Inoue M., Ma L., Aoki J., Chun J., Ueda H. Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain. Mol Pain 2008, 4:6.
15. Jensen T.S., Lenz F.A. Central post-stroke pain: a challenge for the scientist and the clinician. Pain 1995, 61:161-164.
16. Jonsson A.C., Lindgren I., Hallstrom B., Norrving B., Lindgren A. Prevalence and intensity of pain after stroke: a population based study focusing on patients' perspectives. J Neurol Neurosurg Psychiatry 2006, 77:590-595.
17. Kim J.S. Post-stroke pain. Expert Rev Neurother 2009, 9:711-721.
18. Kim J.H., Greenspan J.D., Coghill R.C., Ohara S., Lenz F.A. Lesions limited to the human thalamic principal somatosensory nucleus (ventral caudal) are associated with loss of cold sensations and central pain. J Neurosci 2007, 27:4995-5004.
19. Kim J.S., Bashford G., Murphy T.K., Martin A., Dror V., Cheung R. Safety and efficacy of pregabalin in patients with central post-stroke pain. Pain 2011, 152:1018-1023.
20. Kiso T., Nagakura Y., Toya T., Matsumoto N., Tamura S., Ito H., Okada M., Yamaguchi T. Neurometer measurement of current stimulus threshold in rats. J Pharmacol Exp Ther 2001, 297:352-356.
21. Klit H., Finnerup N.B., Jensen T.S. Central post-stroke pain: clinical characteristics, pathophysiology, and management. Lancet Neurol 2009, 8:857-868.
22. Klit H., Finnerup N.B., Andersen G., Jensen T.S. Central poststroke pain: a population-based study. Pain 2011, 152:818-824.
23. Koga K., Furue H., Rashid M.H., Takaki A., Katafuchi T., Yoshimura M. Selective activation of primary afferent fibers evaluated by sine-wave electrical stimulation. Mol Pain 2005, 1:13.
24. Kong K.H., Woon V.C., Yang S.Y. Prevalence of chronic pain and its impact on health-related quality of life in stroke survivors. Arch Phys Med Rehabil 2004, 85:35-40.
25. Kumar G., Soni C.R. Central post-stroke pain: current evidence. J Neurol Sci 2009, 284:10-17.
26. Kumar B., Kalita J., Kumar G., Misra U.K. Central poststroke pain: a review of pathophysiology and treatment. Anesth Analg 2009, 108:1645-1657.
27. Ma L., Nagai J., Ueda H. Microglial activation mediates de novo lysophosphatidic acid production in a model of neuropathic pain. J Neurochem 2010, 115:643-653.
28. Matsumoto M., Xie W., Ma L., Ueda H. Pharmacological switch in Aβ-fiber stimulation-induced spinal transmission in mice with partial sciatic nerve injury. Mol Pain 2008, 4:25.
29. Melzack R., Wall P.D. Pain mechanisms: a new theory. Science 1965, 150:971-979.
30. Murakami K., Kondo T., Kawase M., Li Y., Sato S., Chen S.F., Chan P.H. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci 1998, 18:205-213.
31. Nagai J., Uchida H., Matsushita Y., Yano R., Ueda M., Niwa M., Aoki J., Chun J., Ueda H. Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine. Mol Pain 2010, 6:78.
32. Ohsawa I., Ishikawa M., Takahashi K., Watanabe M., Nishimaki K., Yamagata K., Katsura K., Katayama Y., Asoh S., Ohta S. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 2007, 13:688-694.
33. Rashid M.H., Inoue M., Kondo S., Kawashima T., Bakoshi S., Ueda H. Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain. J Pharmacol Exp Ther 2003, 304:940-948.
34. Shuaib A., Lees K.R., Lyden P., Grotta J., Davalos A., Davis S.M., Diener H.C., Ashwood T., Wasiewski W.W., Emeribe U., SAINT II Trial Investigators NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 2007, 357:562-571.
35. Sills G.J. The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol 2006, 6:108-113.
36. Sims N.R., Muyderman H. Mitochondria, oxidative metabolism and cell death in stroke. Biochim Biophys Acta 2010, 1802:80-91.
37. Siniscalchi A., Gallelli L., De Sarro G., Malferrari G., Santangelo E. Antiepileptic drugs for central post-stroke pain management. Pharmacol Res 2012, 65:171-175.
38. Treede R.D., Jensen T.S., Campbell J.N., Dostrovsky J.O., Griffin J.W., Hansson P., Hughes R., Nurmikko T., Serra J. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008, 70:1630-1635.
39. Truong D.T., Venna V.R., McCullough L.D., Fitch R.H. Deficits in auditory, cognitive, and motor processing following reversible middle cerebral artery occlusion in mice. Exp Neurol 2012, 238:114-121.
40. Ueda H. Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms. Pharmacol Ther 2006, 109:57-77.
41. Ueda H. Peripheral mechanisms of neuropathic pain - involvement of lysophosphatidic acid receptor-mediated demyelination. Mol Pain 2008, 4:11.
42. Ueda H. Prothymosin alpha and cell death mode switch, a novel target for the prevention of cerebral ischemia-induced damage. Pharmacol Ther 2009, 123:323-333.
43. Widar M., Samuelsson L., Karlsson-Tivenius S., Ahlstrom G. Long-term pain conditions after a stroke. J Rehabil Med 2002, 34:165-170.
44. Yoshita M., Yamada M. Allodynia in the flank after thalamic stroke. J Clin Neurosci 2006, 13:288-291.
45. Zhang L., Schallert T., Zhang Z.G., Jiang Q., Arniego P., Li Q., Lu M., Chopp M. A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J Neurosci Methods 2002, 117:207-214.
46. Zorowitz R., Smout R.J., Gassaway J.A., Horn S.D. Usage of pain medications during stroke rehabilitation: the post-stroke rehabilitation outcome project (PSROP). Top Stroke Rehabil 2006, 12:37-49.